Dosing Options for High and Very High Potency Topical Steroids
For conditions requiring topical steroids higher than medium potency, use high potency (class I-II) topical corticosteroids twice daily for 2-3 weeks, with a maximum of 50g per week, followed by a taper to maintenance therapy. 1, 2
High and Very High Potency Topical Steroid Options
Class I (Very High Potency)
- Clobetasol propionate 0.05% (cream, ointment, gel)
- Apply thin layer twice daily
- Maximum treatment duration: 2 consecutive weeks
- Maximum weekly amount: 50g
- Do not use with occlusive dressings 2
Class II (High Potency)
- Fluocinonide 0.05% (cream, ointment)
Application Guidelines
Initial Treatment Phase:
Maintenance Phase:
Anatomical Considerations
Use lower potency agents on:
- Face
- Neck
- Genitals
- Body folds 1
Higher potency can be used on:
- Palms and soles (thicker skin)
- Trunk
- Extremities (except flexural areas) 1
Monitoring and Precautions
Watch for local adverse effects:
- Skin atrophy
- Telangiectasia
- Striae
- Purpura 1
Systemic adverse effects risk increases with:
HPA axis suppression:
- Monitor for signs of Cushing's syndrome with prolonged use
- Consider morning plasma cortisol or ACTH stimulation tests for patients using large amounts 2
Special Considerations
Tachyphylaxis:
- May occur with prolonged use
- Consider intermittent application schedules to minimize this risk 1
Pediatric patients:
- More susceptible to systemic effects due to larger skin surface to body mass ratio
- Use lower potency steroids when possible 2
Vehicle selection:
- Ointments: Better for dry, scaly conditions (higher potency)
- Creams: Better for weeping lesions
- Gels/solutions: Better for hairy areas 6
Quantity Guidelines
For a 2-week treatment period, approximate amounts needed:
- Face and neck: 15-30g
- Both hands: 15-30g
- Both arms: 30-60g
- Both legs: 100g
- Trunk: 100g 7
High and very high potency topical steroids are effective but require careful monitoring and limited duration of use to minimize adverse effects. After the initial treatment phase, transition to maintenance therapy with medium potency steroids or intermittent application of high potency steroids to prevent recurrence.